"Sexual Health Clinic for the treatment and prevention of Sexually Transmitted Infections"

During the past decade, Melbourne Sexual Health Centre conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 6 clinical trials were completed, i.e. on average, 54.5% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Melbourne Sexual Health Centre" #1 sponsor was "Kirby Institute" with 6 trials, followed by "Gilead Sciences" with 3 trials sponsored, "Andrew Carr" with 2 trials sponsored, "The Alfred" with 2 trials sponsored and "University of Melbourne" with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Melbourne Sexual Health Centre" #1 collaborator was "Merck Sharp & Dohme LLC" with 5 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 4 trials as a collaborator, "The Alfred" with 4 trials as a collaborator, "Abbott" with 2 trials as a collaborator and "Bristol-Myers Squibb" with 2 trials as a collaborator. Other collaborators include 40 different institutions and companies that were collaborators in the rest 46 trials.

According to Clinical.Site data, the most researched conditions in "Melbourne Sexual Health Centre" are "HIV" (8 trials), "HIV Infections" (6 trials), "HIV Infection" (2 trials), "Hepatitis C" (2 trials) and "Human Immunodeficiency Virus" (2 trials). Many other conditions were trialed in "Melbourne Sexual Health Centre" in a lesser frequency.

Most popular intervention types in "Melbourne Sexual Health Centre" are "Drug" (15 trials), "Other" (3 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "ATV" (2 trials), "COBI" (2 trials), "E/C/F/TAF" (2 trials) and "E/C/F/TDF" (2 trials). Other intervention names were less common.

The vast majority of trials in "Melbourne Sexual Health Centre" are 16 trials for "All" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Melbourne Sexual Health Centre". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Melbourne Sexual Health Centre, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Melbourne Sexual Health Centre, 2 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 1 trials that are defined as “Not Applicable".